NIH-funded research R01 grant

Genetic factors shaping Helicobacter pylori infection

Official title: Genetic requirements of Helicobacter pylori infection

Funded at Fred Hutchinson Cancer Center · NIH-11390410 · Data updated 2026-11-12

A scientist is studying how the genetics of the stomach bacterium Helicobacter pylori interact with human hosts to influence infection and disease risk.

More Helicobacter Pylori Infection research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFred Hutchinson Cancer Center
NIH-funded
Lab location1 site (Seattle, United States)
Project startDecember 1, 2003
Project endJune 30, 2031
Funding year2026
Award (this year)$543,827
NIH project number2R01AI054423-22
Project IDNIH-11390410 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with Helicobacter pylori infection or at-risk populations affected by Hp-related stomach disease.

Less likely to help

People not infected with Hp or not at risk for Hp-related diseases may not benefit directly.

What this research studies

Helicobacter pylori infects many people and can lead to serious stomach diseases including ulcers and cancer. This project looks at how bacterial genes, especially those on mobile elements and surface proteins, vary across populations and how admixture and transmission within families influence parasite genetics. The study aims to connect bacterial genetic variation with patterns of stomach inflammation and pre-cancerous changes, considering racial and ethnic disparities in disease outcomes. Researchers will use genetic analysis and bioassays to understand how Hp’s diverse genes contribute to its ability to cause disease in different people.

Why it matters

Potential benefit: Gaining insights into Hp genetics could help tailor prevention, diagnostics, and treatments to reduce severe stomach diseases.

How similar studies have gone: Previous work has linked Hp genetic variation to disease outcomes, but this project advances understanding of intergenomic recombination and mobile genetic elements in relation to human populations.

Where this research is happening

  • Fred Hutchinson Cancer Center
    Seattle, United States
    Active

Researchers

  • Principal investigator: Salama, Nina — Fred Hutchinson Cancer Center
  • Study coordinator: Salama, Nina

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.